Shire says Vyvanse, its once-daily medication approved to treat the symptoms of attention deficit hyperactivity disorder, is now available in US pharmacies nationwide.
In a clinical study, Vyvanse provided consistent ADHD symptom control throughout the day based upon parent reports in the morning (approximately 10am), afternoon (approximately 2pm), and early evening (approximately 6pm).
READ MORE @ PHARMACEUTICAL BUSINESS REVIEW
Showing posts with label Vyvanse. Show all posts
Showing posts with label Vyvanse. Show all posts
Monday, August 6, 2007
Subscribe to:
Posts (Atom)
